| 27. | da Costa LJ, dos Santos AL, Mandic R , Shaw K, de Aguiar RS, Tanur A, Luciw P; Peterlin BM. Interactions between Nef, GagPol and Alix facilitate SIV replication and progression to AIDS in rhesus macaques, manuscript in revision. |
| 26. | Mandic R , Rodgarkia-Dara CJ, Krohn V, Wiegand S, Grénman R, Werner JA. Cisplatin Resistance of the HNSCC Cell Line UT-SCC-26A can be Overcome by Stimulation of the EGF-Receptor, Anticancer Res, in press. |
| 25. | Teymoortash A, Müller F, Juricko J, Bieker M, Mandic R , Librizzi D, Höffken H, Pfestroff A, Werner JA. Botulinum toxin prevents radiotherapy-induced salivary gland damage, Oral Oncology , in press. |
| 24. | Wiegand S, Eivazi B, Barth PJ, von Rautenfeld DB, Folz BJ, Mandic R , Werner JA. Pathogenesis of lymphangiomas. Virchows Arch. 2008;453:1-8. |
| 23. | Schulz S, Häussler U, Mandic R , Heverhagen JT, Neubauer A, Dünne AA, Werner JA, Weihe E, Bette M. Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int. J. Cancer. 2008;122(10):2360-7. |
| 22. | Teymoortash A, Sommer F, Mandic R , Schulz S, Bette M, Aumüller G, Werner JA. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br. J. Pharmacol. 2007;152(1):161-7. |
| 21. | Zhu L, Werner JA, Mandic R . Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer. Anticancer Res. 2007;27(5A):3121-6. |
| 20. | Mandic R , Rodgarkia-Dara CJ, Zhu L, Folz BJ, Bette M, Weihe E, Neubauer A, Werner JA. Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor. FEBS Lett. 2006;580:4793-800. |
| 19. | Mandic R , Schamberger CJ, Müller JF, Geyer M, Zhu L, Carey TE, Grénman R, Dünne AA, Werner JA. Reduced cisplatin sensitivity of HNSCC cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53. Clin. Cancer Res. 2005,11:6845-52 [selected for journal cover caption]. |
| 18. | Mandic R , Ludwig T, Oberleithner H, Werner JA. Evaluation of head and neck squamous cell carcinoma invasiveness by the electrical resistance breakdown assay. Clin. Exp. Metastasis . 2005,21:699-704. |
| 17. | Mandic R , Teymoortash A, Kann P, Werner JA. Sialadenosis of the major salivary glands in a patient with central diabetes insipidus, treated with antidiuretic hormone - implications of aquaporin water channels in the pathomechanism of sialadenosis. Exp. Clin. Endocrinol. Diabetes . 2005;113:205-7. |
| 16. | Dünne AA, Mandic R , Falkenberg S, Dalchow CV, Sesterhenn AM, Werner JA. RT-PCR expression profiling of matrix metalloproteinases and their specific inhibitors in cell lines and fresh biopsies of squamous cell carcinomas of the head and neck. In Vivo. 2005,19:943-8. |
| 15. | Sesterhenn AM, Mandic R , Dunne AA, Werner JA. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies, Anticancer Res, 2005;25:2675-80. |
| 14. | Wiegand S, Dünne AA, Müller HH, Mandic R , Barth P, Davis RK, Werner JA. Meta-analysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer. 2005,104:94-100. |
| 13. | Teymoortash A, Mandic R , Schrader C, Werner JA. Extracellular matrix molecules in chronic obstructive sialadenitis: an immunocytochemical and Western blot investigation. J. Oral. Sci. 2004;46:227-33. |
| 12. | Mandic R , Lieder A, Sadowski M, Peldszus R, Werner JA. Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck. Anticancer Res. 2004;24:973-9. |
| 11. | Dunne AA, Mandic R , Ramaswamy A, Plehn S, Schulz S, Lippert BM, Moll R, Werner JA. Lymphogenic metastatic spread of auricular VX2 carcinoma in New Zealand white rabbits. Anticancer Res. 2002;22:3273-9. |
| 10. | Linnemann T, Zheng YH, Mandic R , Peterlin BM. Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology. 2002;294:246-55. |
| 9. | Geyer M, Yu H, Mandic R , Linnemann T, Zheng YH, Fackler OT, Peterlin BM. Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J Biol Chem. 2002;277:28521-9. |
| 8. | Mandic R , Dunne AA, Eikelkamp N, Ramaswamy A, Schulz S, Teymoortash A, Sesterhenn A, Moll R, Werner JA. Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit. Anticancer Res. 202;202:3281-4. |
| 7. | Mandic R , Opper C, Krappe J, Wesemann W. Platelet sialic acid as a potential pathogenic factor in coronary heart disease. Thromb. Res. 2002;106:137-41. |
| 6. | Werner JA, Rathcke IO, Mandic R . The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin. Exp. Metastasis. 2002;19:275-82. |
| 5. | Mandic R , Eikelkamp N, Peldszus R, Sadowski M, Sesterhenn AM, Dunne AA, Werner JA. Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region. Anticancer Res. 2001;21:3413-8. |
| 4. | Mandic R , Fackler OT, Geyer M, Linnemann T, Zheng YH, Peterlin BM. Negative factor from SIV binds to the catalytic subunit of the V-ATPase to internalize CD4 and to increase viral infectivity. Mol. Biol. Cell. 2001;12:463-73. |
| 3. | Mandic R , Lowe AW. Characterization of an alternatively spliced isoform of rat vesicle associated membrane protein-2 (VAMP-2). FEBS Lett. 1999;451:209-13. |
| 2. | Mandic R , Trimble WS, Lowe AW. Tissue-specific alternative RNA splicing of rat vesicle-associated membrane protein-1 (VAMP-1). Gene . 1997;199:173-9. |
| 1. | Wagner AC, Funck RC, Heymanns J, Mandic R , Maisch B. Anemia with LDH-elevation in a patient with aortic valve replacement. Herz . 1994;19:152-5. |
